2. Learning Centers
  3. Topics
  4. Synaptic Plasticity & Brain Health

Synaptic Plasticity & Brain Health

Neurodegeneration Cellular Degeneration Proteostasis

Synaptic plasticity is the activity-, experience-, development-, and injury-dependent modification of synaptic strength, number, and structure, and it remains a central mechanism for learning, memory, sensory adaptation, and brain health. Long-term potentiation (LTP) and long-term depression (LTD) established the experimental foundation of this field, making activity-dependent synaptic regulation in hippocampal, cortical, and other neural circuits a long-standing focus of neuroscience. Current research defines synaptic plasticity as a multilevel process that includes Hebbian plasticity, homeostatic synaptic scaling, dendritic spine remodeling, AMPA receptor trafficking, NMDA receptor-dependent calcium signaling, CaMKII activation, BDNF/TrkB regulation, and local protein synthesis. These mechanisms support information storage, network stability, and adaptive capacity, and they provide quantifiable readouts for neurodevelopment, cognition, and brain disease models[1][2][3][4][5][6][7].
In brain health and disease research, synaptic plasticity is used to study cognitive decline, Alzheimer’s disease, recovery after brain injury, neuropsychiatric disorders, and rehabilitation-associated circuit remodeling. Alzheimer’s disease research emphasizes that synaptic dysfunction can precede widespread neuronal loss, and Aβ and tau can affect neurotransmission, dendritic spine stability, and network activity at the synaptic level. Translational studies use neuroplasticity as a mechanistic basis for motor rehabilitation, cognitive training, neuromodulation, and pharmacological intervention, but major gaps remain in regional specificity, cell-type resolution, animal-to-human cognitive translation, and the relationship between short-term electrophysiological endpoints and durable behavioral benefit. Future studies should integrate electrophysiology, in vivo imaging, spatial transcriptomics, proteomics, and behavioral endpoints to distinguish adaptive synaptic remodeling, pathological excitotoxicity, and compensatory network activity[8][9][10][11].

  • Products
  • Targets/Pathways
Bioactive Molecules
Cat.No. Product Name Disease Area Target Category
HY-100143 Pentiapine Neurological, Eye or Ear Disease Dopamine Receptor Inhibitors & Agonists
HY-100143R Pentiapine (Standard) / Dopamine Receptor; Reference Standards Reference Standards
HY-100255 Tiodazosin Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease Adrenergic Receptor Inhibitors & Agonists
HY-10035 TTA-P2 Pain; Glucose Metabolism Calcium Channel Inhibitors & Agonists
HY-10035R TTA-P2 (Standard) / Reference Standards; Calcium Channel Reference Standards
HY-100372 E4CPG Neurological, Eye or Ear Disease mGluR Inhibitors & Agonists
HY-100407 JNJ16259685 Parkinson's Disease; Depression mGluR Inhibitors & Agonists
HY-100407R JNJ16259685 (Standard) / Reference Standards; mGluR Reference Standards
HY-100454 CGP 25454A Neurodegenerative Disease Dopamine Receptor Inhibitors & Agonists
HY-100642 3-O-Methyltolcapone Alzheimer's Disease; Parkinson's Disease; Digestive System Inflammation; Cancer; Digestive System Disease Drug Metabolite; COMT; Amyloid-β; Apoptosis; Reactive Oxygen Species (ROS) Inhibitors & Agonists
HY-100642R 3-O-Methyltolcapone (Standard) Neurological, Eye or Ear Disease Reference Standards; Drug Metabolite; COMT; Amyloid-β; Apoptosis; Reactive Oxygen Species (ROS) Reference Standards
HY-100642S 3-O-Methyltolcapone-d7 Cancer; Neurological, Eye or Ear Disease Isotope-Labeled Compounds; Drug Metabolite; COMT; Amyloid-β; Apoptosis; Reactive Oxygen Species (ROS) Isotope-Labeled Compounds
HY-100642S1 3-O-Methyltolcapone-d4 Neurological, Eye or Ear Disease Isotope-Labeled Compounds; Drug Metabolite; COMT; Amyloid-β; Apoptosis; Reactive Oxygen Species (ROS) Isotope-Labeled Compounds
HY-100769 Hypidone hydrochloride Alzheimer's Disease; Obesity; Depression 5-HT Receptor Inhibitors & Agonists
HY-100771 PCC0208009 Cardiovascular Disease; Cancer; Neurological, Eye or Ear Disease Indoleamine 2,3-Dioxygenase (IDO) Inhibitors & Agonists
HY-100808 D-Serine Pain iGluR; Endogenous Metabolite Inhibitors & Agonists
HY-100808R D-Serine (Standard) Neurological, Eye or Ear Disease Reference Standards; iGluR; Endogenous Metabolite Reference Standards
HY-100808S D-Serine-d3 Neurological, Eye or Ear Disease Endogenous Metabolite; iGluR; Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-100811 7-Chlorokynurenic acid Alzheimer's Disease; Parkinson's Disease; Depression; Pain iGluR Inhibitors & Agonists
HY-100811A 7-Chlorokynurenic acid sodium salt Alzheimer's Disease; Parkinson's Disease; Depression; Pain iGluR Inhibitors & Agonists
HY-100811AR 7-Chlorokynurenic acid sodium salt (Standard) Neurological, Eye or Ear Disease Reference Standards; iGluR Reference Standards
HY-100811R 7-Chlorokynurenic acid (Standard) Neurological, Eye or Ear Disease Reference Standards; iGluR Reference Standards
HY-100821 2,4-Dihydroxyphenylacetylasparagine Infection Bacterial Inhibitors & Agonists
HY-100834 5,7-Dichlorokynurenic acid Alzheimer's Disease; Parkinson's Disease; Depression; Pain iGluR Inhibitors & Agonists
HY-100834A 5,7-Dichlorokynurenic acid sodium Neurological, Eye or Ear Disease iGluR Inhibitors & Agonists
HY-100834R 5,7-Dichlorokynurenic acid (Standard) Neurological, Eye or Ear Disease Reference Standards; iGluR Reference Standards
HY-100838 cis-α-(Carboxycyclopropyl)glycine Neurological, Eye or Ear Disease EAAT Peptides
HY-100842A (S)-3C4HPG Neurological, Eye or Ear Disease GABA Receptor Inhibitors & Agonists
HY-100968 GBR 12783 dihydrochloride Neurodegenerative Disease Dopamine Receptor Inhibitors & Agonists
HY-100981 MR-16728 hydrochloride Neurological, Eye or Ear Disease Endogenous Metabolite Inhibitors & Agonists
HY-100998 Metaphit Neurological, Eye or Ear Disease iGluR Inhibitors & Agonists
HY-101013 D-SNAP / Fluorescent Dye Fluorescent Dyes
HY-101226 MSOP Parkinson's Disease; Depression mGluR Inhibitors & Agonists
HY-101226R MSOP (Standard) / Reference Standards; mGluR Reference Standards
HY-101241 MPPG Neurological, Eye or Ear Disease mGluR Inhibitors & Agonists
HY-101322A MM 77 dihydrochloride Neurological, Eye or Ear Disease 5-HT Receptor Inhibitors & Agonists
HY-101334 MPDC Neurological, Eye or Ear Disease GlyT Inhibitors & Agonists
HY-101334A MPDC hydrochloride Neurological, Eye or Ear Disease GlyT Inhibitors & Agonists
HY-101599 IP-66 Blood or Cardio-cerebrovascular Disease Adrenergic Receptor Inhibitors & Agonists
HY-101753A Cianopramine hydrochloride Neurological, Eye or Ear Disease 5-HT Receptor Inhibitors & Agonists
HY-101855 Emrusolmin Alzheimer's Disease; Parkinson's Disease Amyloid-β Inhibitors & Agonists
HY-101855R Emrusolmin (Standard) / Reference Standards; Amyloid-β Reference Standards
HY-10232 THIP Alzheimer's Disease; Parkinson's Disease GABA Receptor Inhibitors & Agonists
HY-10232R THIP (Standard) Neurological, Eye or Ear Disease Reference Standards; GABA Receptor Reference Standards
HY-10232S THIP-d4 Neurological, Eye or Ear Disease Isotope-Labeled Compounds; GABA Receptor Isotope-Labeled Compounds
HY-103156 NAS-181 dimesylate Alzheimer's Disease; Parkinson's Disease 5-HT Receptor Inhibitors & Agonists
HY-103259 Sodium metatungstate Leukemia/Lymphoma/Myeloma; Leukemia/Lymphoma/Myeloma; Digestive System Inflammation; Neurological, Eye or Ear Disease; Digestive System Disease Phosphatase; P2X Receptor; P2Y Receptor; Pyroptosis; Interleukin Related Inhibitors & Agonists
HY-103298 MNI-caged kainate Neurological, Eye or Ear Disease Endogenous Metabolite Inhibitors & Agonists
HY-103467 NPE-caged-HPTS sodium / Fluorescent Dye Inhibitors & Agonists
HY-103518 CGP36216 Neurological, Eye or Ear Disease GABA Receptor Inhibitors & Agonists
HY-103518A CGP36216 hydrochloride Neurological, Eye or Ear Disease GABA Receptor Inhibitors & Agonists
HY-103557 Ro 64-5229 Neurological, Eye or Ear Disease mGluR Inhibitors & Agonists
HY-103559 HexylHIBO Parkinson's Disease; Depression mGluR Inhibitors & Agonists
HY-105161 AP-521 free base Neurological, Eye or Ear Disease 5-HT Receptor Inhibitors & Agonists
HY-105197A BMS-181101 hydrochloride Neurological, Eye or Ear Disease 5-HT Receptor Inhibitors & Agonists
HY-105328 S-14489 Neurological, Eye or Ear Disease 5-HT Receptor Inhibitors & Agonists
HY-105521A Dexnafenodone hydrochloride Neurological, Eye or Ear Disease Adrenergic Receptor Inhibitors & Agonists
HY-106390A GYKI 12743 Neurological, Eye or Ear Disease Adrenergic Receptor Inhibitors & Agonists
HY-106407 Beloxepin Neurological, Eye or Ear Disease Adrenergic Receptor; 5-HT Receptor Inhibitors & Agonists
HY-106469 Taltrimide Neurological, Eye or Ear Disease Drug Derivative Inhibitors & Agonists
HY-106504 Aganodine Neurological, Eye or Ear Disease Imidazoline Receptor Inhibitors & Agonists
HY-106512 Cianergoline / Prostaglandin Receptor Inhibitors & Agonists
HY-106644 Femoxetine Neurological, Eye or Ear Disease 5-HT Receptor Inhibitors & Agonists
HY-106644A Femoxetine hydrochloride Neurological, Eye or Ear Disease 5-HT Receptor Inhibitors & Agonists
HY-106781 OPC-4392 Neurological, Eye or Ear Disease Dopamine Receptor Inhibitors & Agonists
HY-106781A OPC 4392 hydrochloride Neurological, Eye or Ear Disease Dopamine Receptor Inhibitors & Agonists
HY-106888 CS-722 Free base Neurological, Eye or Ear Disease Endogenous Metabolite Inhibitors & Agonists
HY-106888A CS-722 Neurological, Eye or Ear Disease Endogenous Metabolite Inhibitors & Agonists
HY-107498 GNE-8324 Neurological, Eye or Ear Disease iGluR Inhibitors & Agonists
HY-107498R GNE-8324 (Standard) / Reference Standards; iGluR Inhibitors & Agonists
HY-107506 Ro 67-4853 Neurological, Eye or Ear Disease mGluR Inhibitors & Agonists
HY-107601 UBP316 Alzheimer's Disease; Parkinson's Disease; Depression iGluR Inhibitors & Agonists
HY-107605 UBP296 Neurological, Eye or Ear Disease iGluR Inhibitors & Agonists
HY-107717 MNI-caged-NMDA Neurological, Eye or Ear Disease iGluR Inhibitors & Agonists
HY-107811 Harmol Parkinson's Disease; Depression; Digestive System Inflammation; Cancer; Digestive System Disease Mitosis; Autophagy; α-synuclein; Monoamine Oxidase; Apoptosis Inhibitors & Agonists
HY-107811A Harmol hydrochloride Neurological, Eye or Ear Disease Mitosis; Autophagy; α-synuclein; Monoamine Oxidase; Apoptosis Inhibitors & Agonists
HY-107811R Harmol (Standard) Cancer; Neurological, Eye or Ear Disease Mitosis; Autophagy; Reference Standards; α-synuclein; Monoamine Oxidase; Apoptosis Reference Standards
HY-107944 Chlorphenesin carbamate Neurological, Eye or Ear Disease Drug Derivative Inhibitors & Agonists
HY-107944R Chlorphenesin carbamate (Standard) Neurological, Eye or Ear Disease Reference Standards; iGluR Reference Standards
HY-108256 Melitracen hydrochloride Alzheimer's Disease; Parkinson's Disease; Depression 5-HT Receptor Inhibitors & Agonists
HY-108256R Melitracen hydrochloride (Standard) Neurological, Eye or Ear Disease 5-HT Receptor; Reference Standards Reference Standards
HY-108256S Melitracen-d6 hydrochloride Neurological, Eye or Ear Disease Isotope-Labeled Compounds; 5-HT Receptor Isotope-Labeled Compounds
HY-108497 L-803087 Cancer; Neurological, Eye or Ear Disease Somatostatin Receptor Inhibitors & Agonists
HY-108497A L-803087 TFA Cancer; Neurological, Eye or Ear Disease Somatostatin Receptor Inhibitors & Agonists
HY-108497R L-803087 (Standard) / Reference Standards; Somatostatin Receptor Reference Standards
HY-108578 RuBi-4AP Neurological, Eye or Ear Disease Potassium Channel Inhibitors & Agonists
HY-108698A (R)-Preclamol hydrochloride Parkinson's Disease; Depression Dopamine Receptor Inhibitors & Agonists
HY-108698AR (R)-Preclamol hydrochloride (Standard) / Reference Standards; Dopamine Receptor Reference Standards
HY-108973 Ifoxetine hemisulfate Neurological, Eye or Ear Disease 5-HT Receptor Inhibitors & Agonists
HY-108973A Ifoxetine Neurological, Eye or Ear Disease 5-HT Receptor Inhibitors & Agonists
HY-109009 Padsevonil Neurological, Eye or Ear Disease GABA Receptor Inhibitors & Agonists
HY-109009A (S)-Padsevonil Alzheimer's Disease; Parkinson's Disease GABA Receptor Inhibitors & Agonists
HY-109009AR (S)-Padsevonil (Standard) / Reference Standards; GABA Receptor Reference Standards
HY-109009R Padsevonil (Standard) / Reference Standards; GABA Receptor Reference Standards
HY-109046 Tulrampator Alzheimer's Disease; Pancreatic Cancer; Pain; Digestive System Cancer iGluR; mTOR Inhibitors & Agonists
HY-109046R Tulrampator (Standard) / Reference Standards; iGluR; mTOR Reference Standards
HY-10932 Aniracetam SARS-CoV-2 Infection; Neurological, Eye or Ear Disease nAChR; iGluR Inhibitors & Agonists
HY-10932R Aniracetam (Standard) Neurological, Eye or Ear Disease Reference Standards; nAChR; iGluR Reference Standards
HY-10965 Rolofylline Parkinson's Disease; Cancer Adenosine Receptor Inhibitors & Agonists
HY-10965R Rolofylline (Standard) Neurological, Eye or Ear Disease Adenosine Receptor; Reference Standards Reference Standards
HY-110016 Docosatetraenylethanolamide Neurological, Eye or Ear Disease Endogenous Metabolite; Cannabinoid Receptor Inhibitors & Agonists
HY-110032 Lamotrigine isethionate Cancer; Neurological, Eye or Ear Disease Sodium Channel; Autophagy Inhibitors & Agonists
HY-110146 XAP044 Parkinson's Disease; Depression mGluR Inhibitors & Agonists
HY-110175 CX614 Neurological, Eye or Ear Disease iGluR Inhibitors & Agonists
HY-111129 CP-66713 Neurological, Eye or Ear Disease Adenosine Receptor Inhibitors & Agonists
HY-111283 AJ-76 Neurological, Eye or Ear Disease Dopamine Receptor Inhibitors & Agonists
HY-112828 LEI105 Neurological, Eye or Ear Disease; Inflammation or Immune System Disease; Metabolic or Endocrine Disease DAGL Inhibitors & Agonists
HY-113218 Acetyl-L-carnitine Alzheimer's Disease; Parkinson's Disease; Viral Infection; Digestive System Inflammation; Digestive System Disease Caspase; Apoptosis Inhibitors & Agonists
HY-113273A Diadenosine pentaphosphate pentasodium Neurological, Eye or Ear Disease P2X Receptor Inhibitors & Agonists
HY-113273B Diadenosine pentaphosphate pentaammonium Metabolic or Endocrine Disease Endogenous Metabolite Inhibitors & Agonists
HY-113273C Diadenosine pentaphosphate pentalithium Metabolic or Endocrine Disease Endogenous Metabolite Inhibitors & Agonists
HY-113283 Homogentisic acid Alzheimer's Disease; Colorectal Cancer; Purine Metabolism; Digestive System Cancer Amyloid-β; Natriuretic Peptide Receptor (NPR); α-synuclein; Transthyretin (TTR); Claudin Inhibitors & Agonists
HY-113355 NADH Ischemia-Reperfusion Injury; Neurodegenerative Disease; Nervous System Injury; Autoimmune Disease; Renal Disease Endogenous Metabolite; Apoptosis Inhibitors & Agonists
HY-113410 3-Methylglutaric acid Parkinson's Disease; Digestive System Inflammation; Cancer; Metabolic or Endocrine Disease; Digestive System Disease Na+/K+ ATPase; Mitochondrial Metabolism; Reactive Oxygen Species (ROS) Inhibitors & Agonists
HY-113410R 3-Methylglutaric acid (Standard) Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease Reference Standards; Na+/K+ ATPase; Mitochondrial Metabolism; Reactive Oxygen Species (ROS) Reference Standards
HY-113410S 3-Methylglutaric acid-d4 Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease Isotope-Labeled Compounds; Na+/K+ ATPase; Mitochondrial Metabolism; Reactive Oxygen Species (ROS) Isotope-Labeled Compounds
HY-113608 VCP171 Neurological, Eye or Ear Disease Adenosine Receptor Inhibitors & Agonists
HY-113788 PF-719 Alzheimer's Disease; Autoimmune Disease Pyk2; p38 MAPK; Amyloid-β Inhibitors & Agonists
HY-113985 Cirazoline Neurological, Eye or Ear Disease Imidazoline Receptor; Adrenergic Receptor Inhibitors & Agonists
HY-113995 (-)-Vesamicol Parkinson's Disease mAChR Inhibitors & Agonists
HY-114040 NO-711 Neurological, Eye or Ear Disease GABA Receptor Inhibitors & Agonists
HY-114118 Semaglutide Cancer; Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease GLP Receptor; Insulin Receptor; Autophagy; p38 MAPK; α-synuclein; Bcl-2 Family; Apoptosis Peptides
HY-114118A Semaglutide TFA Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease GLP Receptor; Insulin Receptor; Autophagy; p38 MAPK; α-synuclein; Bcl-2 Family; Apoptosis Peptides
HY-114118B Semaglutide acetate Cancer; Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease GLP Receptor; Insulin Receptor; Autophagy; p38 MAPK; α-synuclein; Bcl-2 Family; Apoptosis Peptides
HY-114118C Semaglutide sodium Cancer; Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease GLP Receptor; Insulin Receptor; α-synuclein; Apoptosis; p38 MAPK; Autophagy; Bcl-2 Family Peptides
HY-114118CP Semaglutide (crude) Cancer; Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease GLP Receptor; Insulin Receptor; α-synuclein; Apoptosis; p38 MAPK; Autophagy; Bcl-2 Family Peptides
HY-114118S Semaglutide-d8 Cancer; Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease GLP Receptor; Insulin Receptor; Autophagy; p38 MAPK; α-synuclein; Bcl-2 Family; Apoptosis; Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-114118S1 Semaglutide-d8 tetraTFA Cancer; Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease Isotope-Labeled Compounds; GLP Receptor; Insulin Receptor; α-synuclein; Apoptosis; p38 MAPK; Autophagy; Bcl-2 Family Isotope-Labeled Compounds
HY-114118S3 Semaglutide-13C6,15N TFA Metabolic or Endocrine Disease GLP Receptor; Insulin Receptor; Autophagy; p38 MAPK; α-synuclein; Bcl-2 Family; Apoptosis; Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-114555 TASP0315003 Neurological, Eye or Ear Disease GlyT Inhibitors & Agonists
HY-114613 D-Trp-Aib Alzheimer's Disease; Inflammation or Immune System Disease Amyloid-β; α-synuclein; CGRP Receptor; Amylin Receptor Inhibitors & Agonists
HY-114684 A20832 / Topoisomerase Inhibitors & Agonists
HY-114899 Azamethiphos Infection; Neurological, Eye or Ear Disease Environmental Pollutants; Cholinesterase (ChE); Insecticide Inhibitors & Agonists
HY-114899R Azamethiphos (Standard) Infection; Neurological, Eye or Ear Disease Reference Standards; Cholinesterase (ChE); Insecticide Reference Standards
HY-114899S Azamethiphos-d6 Infection; Neurological, Eye or Ear Disease Isotope-Labeled Compounds; Cholinesterase (ChE); Insecticide Isotope-Labeled Compounds
HY-115038 ELN484228 Parkinson's Disease α-synuclein Inhibitors & Agonists
HY-115739 RTIL 13 Cancer; Neurological, Eye or Ear Disease Ras Inhibitors & Agonists
HY-116076 S-15535 Alzheimer's Disease 5-HT Receptor Inhibitors & Agonists
HY-116143 MAGL-IN-12 Metabolic or Endocrine Disease MAGL Inhibitors & Agonists
HY-116377 DU-14 Neurological, Eye or Ear Disease Steroid Sulfatase Inhibitors & Agonists
HY-116431 I-BOP Neurological, Eye or Ear Disease; Blood or Cardio-cerebrovascular Disease Prostaglandin Receptor Inhibitors & Agonists
HY-116495 (-)-OSU6162 Neurological, Eye or Ear Disease Dopamine Receptor Inhibitors & Agonists
HY-116673 TTK21 Lung Fibrosis; Neurological, Eye or Ear Disease Histone Acetyltransferase Inhibitors & Agonists
HY-116818 Crebinostat Leukemia/Lymphoma/Myeloma; Obesity; Lung Fibrosis; Breast Cancer; Prostate Cancer; Liver Cancer; Leukemia/Lymphoma/Myeloma; Pancreatic Cancer; Pain; Digestive System Cancer; Urogenital Cancer HDAC Inhibitors & Agonists
HY-117160 4-trans-Hydroxy-glibenclamide Neurological, Eye or Ear Disease Potassium Channel Inhibitors & Agonists
HY-117251 LP-403812 Neurological, Eye or Ear Disease Amino acid Transporter Inhibitors & Agonists
HY-117575A WAY-100135 dihydrochloride Alzheimer's Disease; Parkinson's Disease 5-HT Receptor Inhibitors & Agonists
HY-117771 DO34 Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease DAGL Inhibitors & Agonists
HY-118018 CHF-2993 Epilepsy GABA Receptor Inhibitors & Agonists
HY-118646 NS-6740 Chronic Pain; Inflammation or Immune System Disease nAChR; TNF Receptor Inhibitors & Agonists
HY-118646A NS-6740 hydrochloride Pain; Inflammation or Immune System Disease nAChR; TNF Receptor Inhibitors & Agonists
HY-119209 Nefazodone Alzheimer's Disease; Parkinson's Disease; Depression; Inflammation or Immune System Disease 5-HT Receptor; Cytochrome P450 Inhibitors & Agonists
HY-119209R Nefazodone (Standard) Neurological, Eye or Ear Disease; Inflammation or Immune System Disease 5-HT Receptor; Cytochrome P450; Reference Standards Reference Standards
HY-119325 Lanperisone Cancer Apoptosis Inhibitors & Agonists
HY-119325A Lanperisone hydrochloride Cancer Apoptosis Inhibitors & Agonists
HY-119468 Medifoxamine Ocular Hypertension; Depression Dopamine Transporter Inhibitors & Agonists
HY-119615 Mezilamine Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease Adrenergic Receptor Inhibitors & Agonists
HY-119711 NNGH Lung Fibrosis; Pancreatic Cancer; Pain; Digestive System Cancer MMP Inhibitors & Agonists
HY-119857 AGK7 Neurological, Eye or Ear Disease Sirtuin Inhibitors & Agonists
HY-119980 Fluphenazine Viral Infection; Neurodegenerative Disease; Glucose Metabolism; Cancer Sodium Channel; Dopamine Receptor; SARS-CoV Inhibitors & Agonists
HY-119980A Fluphenazine dimaleate Cancer; Infection; Neurological, Eye or Ear Disease Dopamine Receptor; Sodium Channel; SARS-CoV Inhibitors & Agonists
HY-119980B Fluphenazine hydrochloride Cancer; Neurological, Eye or Ear Disease Dopamine Receptor; Sodium Channel; SARS-CoV Inhibitors & Agonists
HY-119980BS Fluphenazine-d6 hydrochloride Cancer; Neurological, Eye or Ear Disease Dopamine Receptor; Sodium Channel; Isotope-Labeled Compounds; SARS-CoV Isotope-Labeled Compounds
HY-119980S Fluphenazine-d8 / Isotope-Labeled Compounds; Sodium Channel; Dopamine Receptor; SARS-CoV Isotope-Labeled Compounds
HY-120034 NCGC 607 Parkinson's Disease; Metabolic or Endocrine Disease Glycosidase; α-synuclein Inhibitors & Agonists
HY-120042 Heptenophos Others Carboxylesterase (CES); Cholinesterase (ChE) Inhibitors & Agonists
HY-120051 Afizagabar Neurological, Eye or Ear Disease GABA Receptor Inhibitors & Agonists
HY-120156 D-520 Parkinson's Disease Dopamine Receptor; α-synuclein; Amyloid-β Inhibitors & Agonists
HY-120170 BMS-466442 Alzheimer's Disease; Hypertension; Depression ASCT; Adrenergic Receptor; Dopamine Transporter Inhibitors & Agonists
HY-120475 PBT434 Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-120475A PBT434 mesylate Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-120475B PBT434 free base / α-synuclein Inhibitors & Agonists
HY-120796 MW108 hydrochloride Neurological, Eye or Ear Disease p38 MAPK Inhibitors & Agonists
HY-121035 7BIO Alzheimer's Disease; Leukemia/Lymphoma/Myeloma; Obesity; Lung Fibrosis; Breast Cancer; Leukemia/Lymphoma/Myeloma; Pancreatic Cancer; Ovarian Cancer; Depression; Digestive System Cancer; Urogenital Cancer CDK; GSK-3 Inhibitors & Agonists
HY-121116 CGS 8216 Neurological, Eye or Ear Disease GABA Receptor Inhibitors & Agonists
HY-121252 Dopal Parkinson's Disease α-synuclein; Apoptosis; Drug Metabolite Inhibitors & Agonists
HY-121252A Dopal (purity>80%) Neurological, Eye or Ear Disease α-synuclein; Apoptosis; Drug Metabolite Inhibitors & Agonists
HY-121252S Dopal-d5 Neurological, Eye or Ear Disease Isotope-Labeled Compounds; α-synuclein; Apoptosis; Drug Metabolite Isotope-Labeled Compounds
HY-121299 m-Chlorophenylbiguanide Neurological, Eye or Ear Disease 5-HT Receptor Inhibitors & Agonists
HY-121318 LK 11 Neurological, Eye or Ear Disease Adrenergic Receptor Inhibitors & Agonists
HY-121503 FD44 Neurological, Eye or Ear Disease Others Inhibitors & Agonists
HY-12153 JNJ-1930942 Neurological, Eye or Ear Disease Cholinesterase (ChE) Inhibitors & Agonists
HY-12191 A-331440 Metabolic or Endocrine Disease Histamine Receptor Inhibitors & Agonists
HY-121964 cis-Piperidine-2,3-dicarboxylic acid Neurological, Eye or Ear Disease iGluR Inhibitors & Agonists
HY-122487 Troriluzole Alzheimer's Disease; Cancer mGluR Inhibitors & Agonists
HY-122487A Troriluzole hydrochloride Neurological, Eye or Ear Disease mGluR Inhibitors & Agonists
HY-123199 Serotonin azidobenzamidine Neurological, Eye or Ear Disease Serotonin Transporter Inhibitors & Agonists
HY-123439 FTY720-C2 Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-12355 Siponimod SARS-CoV-2 Infection; Experimental Autoimmune Encephalomyelitis; Experimental Autoimmune Encephalomyelitis Potassium Channel; LPL Receptor Inhibitors & Agonists
HY-12355A Siponimod hemifumarate Multiple Sclerosis; Neurodegenerative Disease LPL Receptor; Potassium Channel Inhibitors & Agonists
HY-12355R Siponimod (Standard) Neurological, Eye or Ear Disease; Inflammation or Immune System Disease Reference Standards; Potassium Channel; LPL Receptor Reference Standards
HY-12355S Siponimod-d11 Neurological, Eye or Ear Disease; Inflammation or Immune System Disease Potassium Channel; LPL Receptor; Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-123858 VU6001221 Neurological, Eye or Ear Disease nAChR Inhibitors & Agonists
HY-12389 8-Hydroxyamoxapine Neurological, Eye or Ear Disease GlyT Inhibitors & Agonists
HY-123904 UoS12258 Neurological, Eye or Ear Disease iGluR Inhibitors & Agonists
HY-124009 L-Cysteic acid Metabolic or Endocrine Disease Endogenous Metabolite Inhibitors & Agonists
HY-124009R L-Cysteic acid (Standard) / Reference Standards; Endogenous Metabolite Reference Standards
HY-124030 3-Hydroxyphenazepam Neurological, Eye or Ear Disease Drug Metabolite Inhibitors & Agonists
HY-124057 RO5126946 Alzheimer's Disease; Schizophrenia nAChR Inhibitors & Agonists
HY-124501 LY 165163 Alzheimer's Disease; Obesity 5-HT Receptor Inhibitors & Agonists
HY-124751 YTX-465 Neurological, Eye or Ear Disease Stearoyl-CoA Desaturase (SCD) Inhibitors & Agonists
HY-124832 δ-Secretase inhibitor 11 Alzheimer's Disease Caspase; Amyloid-β Inhibitors & Agonists
HY-124876 SynuClean-D Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-124910 BU-E-75 Blood or Cardio-cerebrovascular Disease Histamine Receptor; Adrenergic Receptor Inhibitors & Agonists
HY-12498 GV-58 Neurological, Eye or Ear Disease Calcium Channel Inhibitors & Agonists
HY-124985 VU6010608 Neurological, Eye or Ear Disease mGluR Inhibitors & Agonists
HY-125287 (Rac)-Minzasolmin Parkinson's Disease α-synuclein Inhibitors & Agonists
HY-12546 Brevetoxin B Cancer; Neurological, Eye or Ear Disease Sodium Channel; Apoptosis; Calcium Channel; Potassium Channel; Caspase Inhibitors & Agonists
HY-125784 Viloxazine hydrochloride Alzheimer's Disease; Parkinson's Disease 5-HT Receptor Inhibitors & Agonists
HY-125900 Neocarzilin A / Others Inhibitors & Agonists
HY-125931 Unifiram Alzheimer's Disease; Parkinson's Disease; Multiple Sclerosis; Schizophrenia iGluR Inhibitors & Agonists
HY-125984 Syn-516 Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-126194 Tolcapone 3-β-D-glucuronide / Drug Metabolite; COMT; Amyloid-β; Apoptosis; Reactive Oxygen Species (ROS) Inhibitors & Agonists
HY-128420 Lobeline sulfate Neurological, Eye or Ear Disease nAChR; Dopamine Transporter Inhibitors & Agonists
HY-129097 FFN-102 trifluoroacetate / Fluorescent Dye Inhibitors & Agonists
HY-129408 SGE-516 Neurological, Eye or Ear Disease GABA Receptor Inhibitors & Agonists
HY-129517 UBP714 Neurological, Eye or Ear Disease iGluR Inhibitors & Agonists
HY-12961A Bretylium tosylate Depression Adrenergic Receptor Inhibitors & Agonists
HY-12961AR Bretylium tosylate (Standard) Neurological, Eye or Ear Disease Reference Standards; Adrenergic Receptor Reference Standards
HY-129682 LY125180 Neurological, Eye or Ear Disease Dopamine Receptor; Adrenergic Receptor; 5-HT Receptor Inhibitors & Agonists
HY-130398 Aerophobin-2 Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-130553 β-Spaglumic acid Parkinson's Disease; Depression Aminopeptidase; mGluR Inhibitors & Agonists
HY-131527 Wy-45494 hydrochloride Depression; Metabolic or Endocrine Disease Serotonin Transporter Inhibitors & Agonists
HY-131556 4-Iodoamphetamine hydrochloride Neurological, Eye or Ear Disease 5-HT Receptor Inhibitors & Agonists
HY-131686 Ganglioside GT1b (bovine) ammonium Cancer; Infection; Neurological, Eye or Ear Disease; Inflammation or Immune System Disease; Metabolic or Endocrine Disease Akt; mTOR; EGFR; ERK Inhibitors & Agonists
HY-131686A Ganglioside GT1b (porcine) ammonium Cancer; Infection; Neurological, Eye or Ear Disease; Inflammation or Immune System Disease; Metabolic or Endocrine Disease Akt; mTOR; EGFR; ERK Inhibitors & Agonists
HY-131885 RuBi-Glutamate hexafluorophosphate sodium Huntington's Disease GABA Receptor Inhibitors & Agonists
HY-133968 24-Methylenecholesterol Parkinson's Disease; Pain; Inflammation or Immune System Disease Acyltransferase; Reactive Oxygen Species (ROS) Inhibitors & Agonists
HY-133968R 24-Methylenecholesterol (Standard) Inflammation or Immune System Disease Reference Standards; Acyltransferase; Reactive Oxygen Species (ROS) Reference Standards
HY-133968S1 24-Methylenecholesterol-13C Inflammation or Immune System Disease Acyltransferase; Isotope-Labeled Compounds; Reactive Oxygen Species (ROS) Isotope-Labeled Compounds
HY-134261 8-Br-ADPR Metastatic Melanoma; Glucose Metabolism TRP Channel; CaMK Inhibitors & Agonists
HY-134261A 8-Br-ADPR disodium Immunotherapy for Melanoma; Leukemia/Lymphoma/Myeloma; Leukemia/Lymphoma/Myeloma; Cancer Immunology; Glucose Metabolism CaMK; TRP Channel Inhibitors & Agonists
HY-13527 LY310762 Alzheimer's Disease; Parkinson's Disease; Hypertension 5-HT Receptor Inhibitors & Agonists
HY-135507A NAS-181 free base Neurological, Eye or Ear Disease 5-HT Receptor Inhibitors & Agonists
HY-135902 Synucleozid Neurological, Eye or Ear Disease DNA/RNA Synthesis Inhibitors & Agonists
HY-135902A Synucleozid hydrochloride Parkinson's Disease DNA/RNA Synthesis Inhibitors & Agonists
HY-136873 UCB-J Epilepsy Synaptic Vesicle Proteins Inhibitors & Agonists
HY-136873A (Rac)-UCB-J Epilepsy Synaptic Vesicle Proteins Inhibitors & Agonists
HY-137108 Sp-8-pCPT-cGMPS Neurological, Eye or Ear Disease PKA; PKG Inhibitors & Agonists
HY-138669 C004019 Neurological, Eye or Ear Disease PROTACs; Tau Protein Inhibitors & Agonists
HY-139692 EAAT2 activator 1 Neurological, Eye or Ear Disease EAAT Inhibitors & Agonists
HY-13999 Amdiglurax Glucose Metabolism; Neurological, Eye or Ear Disease Trk Receptor Inhibitors & Agonists
HY-13999A1 Amdiglurax phosphate Depression; Glucose Metabolism Trk Receptor Inhibitors & Agonists
HY-141554 Dihydrotetrabenazine Neurological, Eye or Ear Disease Monoamine Transporter Inhibitors & Agonists
HY-141554A (2S,3S,11bR)-Dihydrotetrabenazine Neurological, Eye or Ear Disease Monoamine Transporter Inhibitors & Agonists
HY-14472 Tesofensine Obesity; Depression Dopamine Transporter; Serotonin Transporter Inhibitors & Agonists
HY-14472R Tesofensine (Standard) Metabolic or Endocrine Disease Dopamine Transporter; Serotonin Transporter; Reference Standards Reference Standards
HY-145155 Calpain-2-IN-1 Leukemia/Lymphoma/Myeloma; Leukemia/Lymphoma/Myeloma; Neurodegenerative Disease Proteasome Inhibitors & Agonists
HY-145454 (R)-Preclamol Neurological, Eye or Ear Disease Dopamine Receptor Inhibitors & Agonists
HY-145454A Preclamol Neurological, Eye or Ear Disease Dopamine Receptor Inhibitors & Agonists
HY-145475 Nervonoyl ethanolamide Neurological, Eye or Ear Disease; Inflammation or Immune System Disease Cannabinoid Receptor Inhibitors & Agonists
HY-145580 Minzasolmin Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-145580A (S)-Minzasolmin Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-14563 VU10010 Neurological, Eye or Ear Disease mAChR Inhibitors & Agonists
HY-145761 AMPA-IN-1 Neurological, Eye or Ear Disease iGluR Inhibitors & Agonists
HY-14607 Besipirdine hydrochloride Neurological, Eye or Ear Disease Potassium Channel Inhibitors & Agonists
HY-14785 Befiradol Neurological, Eye or Ear Disease 5-HT Receptor Inhibitors & Agonists
HY-14785A Befiradol hydrochloride Alzheimer's Disease; Obesity; Depression 5-HT Receptor Inhibitors & Agonists
HY-148283 WAY-309236 / Drug Derivative Inhibitors & Agonists
HY-148977 18:0,22:6 PS sodium Metabolic or Endocrine Disease Endogenous Metabolite Inhibitors & Agonists
HY-149065 D-685 Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-149509 α-Synuclein inhibitor 9 Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-150209 MODAG-001 Neurological, Eye or Ear Disease Fluorescent Dye Inhibitors & Agonists
HY-152171 GZ-11608 Neurological, Eye or Ear Disease Monoamine Transporter Inhibitors & Agonists
HY-153416 QR-0217 Alzheimer's Disease; Parkinson's Disease Amyloid-β Inhibitors & Agonists
HY-155659 4A7C-301 Parkinson's Disease Nuclear Hormone Receptor 4A/NR4A Inhibitors & Agonists
HY-155811 DQP-997-74 Alzheimer's Disease; Parkinson's Disease; Depression; Pain iGluR Inhibitors & Agonists
HY-156104 CaMKIIα-PHOTAC Neurological, Eye or Ear Disease CaMK; PROTACs Inhibitors & Agonists
HY-156586 Egalognastat Alzheimer's Disease; Parkinson's Disease OGA; Tau Protein Inhibitors & Agonists
HY-156898 NPT100-18A Parkinson's Disease α-synuclein; Caspase; Reactive Oxygen Species (ROS) Inhibitors & Agonists
HY-157072 WAY-311474 / Drug Derivative Inhibitors & Agonists
HY-157225 Brazilin-7-acetate Metabolic or Endocrine Disease α-synuclein Inhibitors & Agonists
HY-157839 PROTAC α-Synuclein/Tau degrader 1 Parkinson's Disease PROTACs; α-synuclein; Tau Protein Inhibitors & Agonists
HY-157999 SDI-118 Neurological, Eye or Ear Disease Synaptic Vesicle Proteins Inhibitors & Agonists
HY-159152 PQM-164 Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-16009 Buntanetap Alzheimer's Disease; Parkinson's Disease; Inflammation or Immune System Disease α-synuclein Inhibitors & Agonists
HY-16009B Buntanetap L-Tartrate Alzheimer's Disease; Parkinson's Disease Amyloid-β Inhibitors & Agonists
HY-160116 α-Synuclein aggregate binder 1 Neurological, Eye or Ear Disease Radionuclide-Drug Conjugates (RDCs); Fluorescent Dye; α-synuclein Inhibitors & Agonists
HY-160426 Gcase activator 3 Neurological, Eye or Ear Disease Glycosidase Inhibitors & Agonists
HY-160831 PQQ-trimethylester Parkinson's Disease α-synuclein Inhibitors & Agonists
HY-160959 AN317 Alzheimer's Disease nAChR Inhibitors & Agonists
HY-162566 REM127 Alzheimer's Disease Molecular Glues; Calcium Channel; Amyloid-β; Tau Protein Inhibitors & Agonists
HY-162860 FO-4-15 Neurological, Eye or Ear Disease mGluR; CaMK; Tau Protein Inhibitors & Agonists
HY-163145 α-Synuclein inhibitor 11 Parkinson's Disease α-synuclein Inhibitors & Agonists
HY-163455 pan-HCN-IN-1 Neurological, Eye or Ear Disease HCN Channel Inhibitors & Agonists
HY-163739 LETC Parkinson's Disease α-synuclein Inhibitors & Agonists
HY-164288 TDI-6570 Alzheimer's Disease; Parkinson's Disease; Systemic Lupus Erythematosus Cyclic GMP-AMP Synthase; STING Inhibitors & Agonists
HY-16468A Squalamine phosphate Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-164703 Lumateperone metabolite 1 Neurological, Eye or Ear Disease Drug Metabolite; Dopamine Receptor; 5-HT Receptor Inhibitors & Agonists
HY-164795 SBI-810 Acute Pain; Postoperative Pain; Mechanical Allodymia Neurotensin Receptor; Arrestin; iGluR; ERK; Sodium Channel Inhibitors & Agonists
HY-164795A SBI-810 hydrochloride Acute Pain; Postoperative Pain; Mechanical Allodymia Neurotensin Receptor; Arrestin; iGluR; ERK; Sodium Channel Inhibitors & Agonists
HY-16525 XEN-2174 Neurological, Eye or Ear Disease Monoamine Transporter; Adrenergic Receptor Peptides
HY-165474 TDPAM01 / iGluR Inhibitors & Agonists
HY-165475 TDPAM02 / iGluR Inhibitors & Agonists
HY-165539 SMER10 / Autophagy; Atg8/LC3; Huntingtin; α-synuclein Inhibitors & Agonists
HY-16689 VU 0240551 Alzheimer's Disease Potassium Channel Inhibitors & Agonists
HY-167832 PT109 Glioblastoma; Alzheimer's Disease; CNS Neoplasm JNK; SGK; ROCK; Tau Protein; MMP; DNA/RNA Synthesis; Pyruvate Kinase; NF-κB; COX; NO Synthase; Reactive Oxygen Species (ROS) Inhibitors & Agonists
HY-168647 KAC-50.1 Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-168771 gamma-DGG TFA Neurological, Eye or Ear Disease iGluR Inhibitors & Agonists
HY-168966 JNJ-54082730 Neurological, Eye or Ear Disease Phosphodiesterase (PDE); iGluR Inhibitors & Agonists
HY-16923 Crobenetine Neurological, Eye or Ear Disease Sodium Channel Inhibitors & Agonists
HY-16923A Crobenetine hydrochloride Neurological, Eye or Ear Disease Sodium Channel Inhibitors & Agonists
HY-169288 α-Synuclein modulator 1 Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-16934 ML352 Neurological, Eye or Ear Disease Cholinesterase (ChE) Inhibitors & Agonists
HY-169871 Argiotoxin 636 Neurological, Eye or Ear Disease iGluR Inhibitors & Agonists
HY-170035 GlcCer (d18:1/18:0) Parkinson's Disease; Liver Cancer; Fungal Infection; Digestive System Cancer Fungal; Wnt; β-catenin Inhibitors & Agonists
HY-17018A Napitane mesylate Neurological, Eye or Ear Disease Adrenergic Receptor Inhibitors & Agonists
HY-170553 ZPD-2 Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-171705 KMS99220 Parkinson's Disease Keap1-Nrf2; AMPK; JNK; IKK; p38 MAPK; NO Synthase; α-synuclein; Interleukin Related Inhibitors & Agonists
HY-171794 AZD1134 Neurological, Eye or Ear Disease 5-HT Receptor Inhibitors & Agonists
HY-171979 Fluorolintane Neurological, Eye or Ear Disease iGluR Inhibitors & Agonists
HY-172531 Sulfonadyn-47 Neurological, Eye or Ear Disease Dynamin; Ras Inhibitors & Agonists
HY-173049 2N4R Tau/α-Syn against-1 Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-173371 BRI-50460 Alzheimer's Disease Phospholipase Inhibitors & Agonists
HY-17406 Tolcapone SARS-CoV-2 Infection; Alzheimer's Disease; Parkinson's Disease; Digestive System Inflammation; Cancer; Digestive System Disease COMT; Amyloid-β; Apoptosis; Reactive Oxygen Species (ROS) Inhibitors & Agonists
HY-17406R Tolcapone (Standard) Cancer; Neurological, Eye or Ear Disease Reference Standards; COMT; Amyloid-β; Apoptosis; Reactive Oxygen Species (ROS) Reference Standards
HY-17406S Tolcapone-d7 Cancer; Neurological, Eye or Ear Disease Isotope-Labeled Compounds; COMT; Amyloid-β; Apoptosis; Reactive Oxygen Species (ROS) Isotope-Labeled Compounds
HY-17406S1 Tolcapone-d4 Neurological, Eye or Ear Disease Isotope-Labeled Compounds; COMT; Amyloid-β; Apoptosis; Reactive Oxygen Species (ROS) Isotope-Labeled Compounds
HY-174146 5-HT1A agonist 1 Neurological, Eye or Ear Disease 5-HT Receptor Inhibitors & Agonists
HY-174462 AChE-IN-90 Neurological, Eye or Ear Disease Cholinesterase (ChE) Inhibitors & Agonists
HY-175100 HexylHIBO hydrobromide / mGluR Inhibitors & Agonists
HY-175296 EAAT2 activator 2 Neurological, Eye or Ear Disease EAAT Inhibitors & Agonists
HY-175300 AChE-IN-92 Neurological, Eye or Ear Disease Cholinesterase (ChE) Inhibitors & Agonists
HY-175308 α-Synuclein inhibitor 15 Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-175737 α-synuclein-IN-16 Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-175748 MK-7337 Alzheimer's Disease Radionuclide-Drug Conjugates (RDCs); α-synuclein Inhibitors & Agonists
HY-17637 Lumateperone Alzheimer's Disease; Cancer Dopamine Receptor; 5-HT Receptor Inhibitors & Agonists
HY-17637R Lumateperone (Standard) Cancer; Neurological, Eye or Ear Disease Dopamine Receptor; 5-HT Receptor; Reference Standards Reference Standards
HY-17637S2 Lumateperone-d4 Cancer; Neurological, Eye or Ear Disease Dopamine Receptor; 5-HT Receptor; Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-176712 GSNOR-IN-1 Neurological, Eye or Ear Disease GSNOR; Apoptosis Inhibitors & Agonists
HY-176866 Rodin-A Neurological, Eye or Ear Disease HDAC Inhibitors & Agonists
HY-176867 Rodin-B Neurological, Eye or Ear Disease HDAC Inhibitors & Agonists
HY-177647 Movronersen Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-177647A Movronersen sodium Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-178153 BPAM363 Neurological, Eye or Ear Disease iGluR Inhibitors & Agonists
HY-178276 α-Synuclein-IN-18 Parkinson's Disease α-synuclein Inhibitors & Agonists
HY-178323 MW073 Neurological, Eye or Ear Disease 5-HT Receptor; Arrestin Inhibitors & Agonists
HY-178920 α-Synuclein-IN-17 Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-179390 KMCA-0011 Depression Adrenergic Receptor Inhibitors & Agonists
HY-180554 UCB1244283 Epilepsy Synaptic Vesicle Proteins Inhibitors & Agonists
HY-180779 SR-1815 Neurological, Eye or Ear Disease Ras Inhibitors & Agonists
HY-180976 Arg-PEG1-Tαsyn Parkinson's Disease PROTACs; α-synuclein Inhibitors & Agonists
HY-181046 Multi-kinase-IN-14 Alzheimer's Disease; Parkinson's Disease α-synuclein; Bcr-Abl; GSK-3; DYRK; LRRK2; Microtubule/Tubulin Inhibitors & Agonists
HY-181672 PI3K/AKT/ERK/CREB activator 1 Alzheimer's Disease PI3K; Akt; ERK; Epigenetic Reader Domain Inhibitors & Agonists
HY-181926 COX-2/HDAC6-IN-1 Alzheimer's Disease COX; HDAC; Microtubule/Tubulin; Interleukin Related; Amyloid-β; Tau Protein Inhibitors & Agonists
HY-182381 FLA-797 Neurological, Eye or Ear Disease Dopamine Receptor Inhibitors & Agonists
HY-182631 CX1763 Neurological, Eye or Ear Disease iGluR Inhibitors & Agonists
HY-182677 EF-7412 Neurological, Eye or Ear Disease 5-HT Receptor; Dopamine Receptor Inhibitors & Agonists
HY-182707 JWX-A0108 Alzheimer's Disease; Schizophrenia nAChR; Interleukin Related; TNF Receptor; NF-κB Inhibitors & Agonists
HY-182893 SK-129 Alzheimer's Disease α-synuclein; Reactive Oxygen Species (ROS); Tyrosine Hydroxylase Inhibitors & Agonists
HY-183101 AMPAR modulator-12 Depression iGluR; NADPH Oxidase Inhibitors & Agonists
HY-183269 SERT-IN-5 Depression; Anxiety or Fear-Related Disease Serotonin Transporter Inhibitors & Agonists
HY-183665 GBR-13119 Parkinson's Disease Dopamine Receptor Inhibitors & Agonists
HY-183910 Pitrazepin Depression GABA Receptor; Glycine Receptor (GlyR) Inhibitors & Agonists
HY-184140 AChE-IN-117 Others Insecticide; nAChR; Cholinesterase (ChE) Inhibitors & Agonists
HY-185659 6'-BPANeuGc Inflammation or Immune System Disease CD22; Apoptosis; Akt; ERK Inhibitors & Agonists
HY-18610 Diclofensine hydrochloride Neurological, Eye or Ear Disease Dopamine Transporter; Adrenergic Receptor; 5-HT Receptor Inhibitors & Agonists
HY-18610A Diclofensine Neurological, Eye or Ear Disease Dopamine Transporter; Adrenergic Receptor; 5-HT Receptor Inhibitors & Agonists
HY-18610R Diclofensine hydrochloride (Standard) Neurological, Eye or Ear Disease Reference Standards; Dopamine Transporter; Adrenergic Receptor; 5-HT Receptor Reference Standards
HY-18610S Diclofensine-d3 hydrochloride Neurological, Eye or Ear Disease Dopamine Transporter; Isotope-Labeled Compounds; Adrenergic Receptor; 5-HT Receptor Isotope-Labeled Compounds
HY-18686 AS1949490 Breast Cancer; Pancreatic Cancer; Pain; Digestive System Inflammation; Glucose Metabolism; Digestive System Cancer Phosphatase; Akt Inhibitors & Agonists
HY-19021 ADD-17014 Neurological, Eye or Ear Disease mGluR Inhibitors & Agonists
HY-19733 Lumateperone tosylate SARS-CoV-2 Infection; Alzheimer's Disease; Parkinson's Disease; Cancer 5-HT Receptor; Dopamine Receptor Inhibitors & Agonists
HY-19733S Lumateperone-13C,d3 tosylate Cancer; Neurological, Eye or Ear Disease Dopamine Receptor; 5-HT Receptor; Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-19793 RS-1 Cancer RAD51 Inhibitors & Agonists
HY-401209 Synucleozid-2.0 Parkinson's Disease α-synuclein; DNA/RNA Synthesis Inhibitors & Agonists
HY-47595 WAY-621089 / Drug Derivative Inhibitors & Agonists
HY-47596 WAY-612453 / Drug Derivative Inhibitors & Agonists
HY-47599 WAY-639418 / Drug Derivative Inhibitors & Agonists
HY-47600 WAY-323756 / Drug Derivative Inhibitors & Agonists
HY-49075 WAY-622252 / Drug Derivative Inhibitors & Agonists
HY-49450 WAY-385995 / Drug Derivative Inhibitors & Agonists
HY-49458 WAY-232897 / Drug Derivative Inhibitors & Agonists
HY-49460 WAY-639299 / Drug Derivative Inhibitors & Agonists
HY-49601 WAY-329738 / Drug Derivative Inhibitors & Agonists
HY-A0081 Fluphenazine dihydrochloride Cancer; Neurological, Eye or Ear Disease Dopamine Receptor; SARS-CoV; Sodium Channel Inhibitors & Agonists
HY-A0081R Fluphenazine dihydrochloride (Standard) Cancer; Neurological, Eye or Ear Disease Reference Standards; Dopamine Receptor; SARS-CoV; Sodium Channel Reference Standards
HY-A0171A Benzoctamine hydrochloride Neurological, Eye or Ear Disease 5-HT Receptor Inhibitors & Agonists
HY-A0183 Phosphatidylserine Inflammation or Immune System Disease Akt; TGF-β Receptor Inhibitors & Agonists
HY-B0007 Baclofen SARS-CoV-2 Infection; Alzheimer's Disease; Parkinson's Disease; Depression GABA Receptor Inhibitors & Agonists
HY-B0007C Baclofen hydrochloride Alzheimer's Disease; Parkinson's Disease; Depression GABA Receptor Inhibitors & Agonists
HY-B0007R Baclofen (Standard) Neurological, Eye or Ear Disease Reference Standards; GABA Receptor Reference Standards
HY-B0007S Baclofen-d4 Neurological, Eye or Ear Disease Isotope-Labeled Compounds; GABA Receptor Isotope-Labeled Compounds
HY-B0007S2 Baclofen-d5 hydrochloride Neurological, Eye or Ear Disease GABA Receptor; Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-B0098 Doxazosin Alzheimer's Disease; Hypertension; Prostate Cancer; Depression; Urogenital Cancer; Metabolic or Endocrine Disease Adrenergic Receptor Inhibitors & Agonists
HY-B0098A Doxazosin mesylate Alzheimer's Disease; Hypertension; Prostate Cancer; Depression; Digestive System Inflammation; Urogenital Cancer; Metabolic or Endocrine Disease; Digestive System Disease Adrenergic Receptor; Autophagy; Mitophagy Inhibitors & Agonists
HY-B0098AR Doxazosin mesylate (Standard) Cancer; Blood or Cardio-cerebrovascular Disease; Metabolic or Endocrine Disease Reference Standards; Adrenergic Receptor; Autophagy; Mitophagy Reference Standards
HY-B0098B (R)-Doxazosin Metabolic or Endocrine Disease Adrenergic Receptor Inhibitors & Agonists
HY-B0098C (S)-Doxazosin / Adrenergic Receptor Inhibitors & Agonists
HY-B0098S Doxazosin-d8 Blood or Cardio-cerebrovascular Disease; Metabolic or Endocrine Disease Isotope-Labeled Compounds; Adrenergic Receptor Isotope-Labeled Compounds
HY-B0106 Levetiracetam Cancer; Neurological, Eye or Ear Disease DNA Methyltransferase Inhibitors & Agonists
HY-B0106R Levetiracetam (Standard) Cancer; Neurological, Eye or Ear Disease Reference Standards; DNA Methyltransferase Reference Standards
HY-B0106S Levetiracetam-d6 Cancer; Neurological, Eye or Ear Disease Isotope-Labeled Compounds; DNA Methyltransferase Isotope-Labeled Compounds
HY-B0106S1 Levetiracetam-d3 Cancer; Neurological, Eye or Ear Disease DNA Methyltransferase Isotope-Labeled Compounds
HY-B0194 Tizanidine Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease Adrenergic Receptor; Apoptosis; Akt; Wnt; β-catenin Inhibitors & Agonists
HY-B0194A Tizanidine hydrochloride Hypertension; Leukemia/Lymphoma/Myeloma; Obesity; Lung Fibrosis; Rheumatoid Arthritis; Lung Cancer; Breast Cancer; Colorectal Cancer; Prostate Cancer; Gastric Cancer; Liver Cancer; Leukemia/Lymphoma/Myeloma; Pancreatic Cancer; Ovarian Cancer; Depression; Pain; Autoimmune Disease; Digestive System Inflammation; Digestive System Cancer; Urogenital Cancer Adrenergic Receptor; Apoptosis; Akt; Wnt; β-catenin Inhibitors & Agonists
HY-B0194AR Tizanidine hydrochloride (Standard) Lung Cancer; Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease Reference Standards; Adrenergic Receptor; Apoptosis; Akt; Wnt; β-catenin Reference Standards
HY-B0194AS Tizanidine-d4 hydrochloride Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease Isotope-Labeled Compounds; Adrenergic Receptor; Apoptosis; Akt; Wnt; β-catenin Isotope-Labeled Compounds
HY-B0194R Tizanidine (Standard) Lung Cancer; Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease Reference Standards; Adrenergic Receptor; Apoptosis; Akt; Wnt; β-catenin Reference Standards
HY-B0194S Tizanidine-d4 Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease Isotope-Labeled Compounds; Adrenergic Receptor; Apoptosis; Akt; Wnt; β-catenin Isotope-Labeled Compounds
HY-B0495 Lamotrigine SARS-CoV-2 Infection; Viral Infection; Cancer; Neurological, Eye or Ear Disease Sodium Channel; Autophagy Inhibitors & Agonists
HY-B0495A Lamotrigine hydrate Cancer; Neurological, Eye or Ear Disease Sodium Channel; Autophagy Inhibitors & Agonists
HY-B0495R Lamotrigine (Standard) Neurological, Eye or Ear Disease Reference Standards; Sodium Channel Reference Standards
HY-B0495S Lamotrigine-13C3,d3 Neurological, Eye or Ear Disease Isotope-Labeled Compounds; Sodium Channel; Autophagy Isotope-Labeled Compounds
HY-B0495S1 Lamotrigine-13C,d3 Neurological, Eye or Ear Disease Isotope-Labeled Compounds; Sodium Channel; Autophagy Isotope-Labeled Compounds
HY-B0495S3 Lamotrigine-13C2,15N Neurological, Eye or Ear Disease Autophagy; Sodium Channel Isotope-Labeled Compounds
HY-B0495S4 Lamotrigine-13C3 Neurological, Eye or Ear Disease Sodium Channel; Autophagy Isotope-Labeled Compounds
HY-B0495S5 Lamotrigine-d3 Neurological, Eye or Ear Disease Autophagy; Sodium Channel Isotope-Labeled Compounds
HY-B0495S6 Lamotrigine-13C2,15N2,d3 Cancer; Neurological, Eye or Ear Disease Autophagy; Sodium Channel; Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-B0495S7 Lamotrigine-13C Cancer; Neurological, Eye or Ear Disease Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-B0495S8 Lamotrigine-13C7,15N Cancer; Neurological, Eye or Ear Disease Autophagy; Sodium Channel; Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-B0512 Sulfamerazine Parkinson's Disease; Bacterial Infection Antibiotic; Bacterial; α-synuclein Inhibitors & Agonists
HY-B0512A Sulfamerazine sodium Parkinson's Disease; Bacterial Infection Antibiotic; Bacterial; α-synuclein Inhibitors & Agonists
HY-B0527 Amitriptyline Alzheimer's Disease; Parkinson's Disease; Hypertension; Obesity; Viral Infection; Depression; Pain; Digestive System Inflammation; Digestive System Disease Adrenergic Receptor; 5-HT Receptor; mAChR; Histamine Receptor; Sodium Channel; Serotonin Transporter; Trk Receptor; Potassium Channel; Dopamine Transporter; Apoptosis Inhibitors & Agonists
HY-B0527A Amitriptyline hydrochloride Alzheimer's Disease; Parkinson's Disease; Hypertension; Obesity; Viral Infection; Depression; Pain; Digestive System Inflammation; Digestive System Disease Serotonin Transporter; 5-HT Receptor; mAChR; Histamine Receptor; Adrenergic Receptor; Trk Receptor; Sodium Channel; Potassium Channel; Dopamine Transporter; Apoptosis Inhibitors & Agonists
HY-B0527AR Amitriptyline hydrochloride (Standard) Neurological, Eye or Ear Disease; Inflammation or Immune System Disease; Metabolic or Endocrine Disease Reference Standards; Serotonin Transporter; 5-HT Receptor; Histamine Receptor; mAChR; Adrenergic Receptor; Trk Receptor; Sodium Channel; Potassium Channel; Dopamine Transporter; Apoptosis Reference Standards
HY-B0527AS Amitriptyline-d6 hydrochloride Neurological, Eye or Ear Disease; Inflammation or Immune System Disease; Metabolic or Endocrine Disease Isotope-Labeled Compounds; Serotonin Transporter; 5-HT Receptor; Histamine Receptor; mAChR; Adrenergic Receptor; Trk Receptor; Sodium Channel; Potassium Channel; Dopamine Transporter; Apoptosis Isotope-Labeled Compounds
HY-B0570 Decamethonium Bromide Alzheimer's Disease nAChR Inhibitors & Agonists
HY-B0590 Tetrabenazine Neurological, Eye or Ear Disease Monoamine Transporter; Dopamine Receptor Inhibitors & Agonists
HY-B0590A Tetrabenazine Racemate Neurological, Eye or Ear Disease Monoamine Transporter; Dopamine Receptor Inhibitors & Agonists
HY-B0590E Tetrabenazine mesylate Neurological, Eye or Ear Disease Monoamine Transporter; Dopamine Receptor Inhibitors & Agonists
HY-B0590R Tetrabenazine (Standard) Huntington's Disease Reference Standards; Monoamine Transporter; Dopamine Receptor Reference Standards
HY-B0590S Tetrabenazine-d6 Huntington's Disease Monoamine Transporter Isotope-Labeled Compounds
HY-B0590S3 Tetrabenazine-d7 Huntington's Disease Monoamine Transporter; Isotope-Labeled Compounds; Dopamine Receptor Isotope-Labeled Compounds
HY-B0649 Propofol Non-Small Cell Lung Cancer; Alzheimer's Disease; Parkinson's Disease; Breast Cancer; Prostate Cancer; Pancreatic Cancer; Depression; Respiratory Cancer; Digestive System Cancer; Urogenital Cancer Environmental Pollutants; GABA Receptor; Endogenous Metabolite Inhibitors & Agonists
HY-B0649R Propofol (Standard) Cancer; Neurological, Eye or Ear Disease Reference Standards; GABA Receptor; Endogenous Metabolite Reference Standards
HY-B0649S Propofol-d17 Neurological, Eye or Ear Disease GABA Receptor; Endogenous Metabolite Isotope-Labeled Compounds
HY-B0649S1 Propofol-d18 Neurological, Eye or Ear Disease GABA Receptor; Endogenous Metabolite Isotope-Labeled Compounds
HY-B0678 Metaxalone SARS-CoV-2 Infection; Parkinson's Disease; Leukemia/Lymphoma/Myeloma; Obesity; Breast Cancer; Prostate Cancer; Liver Cancer; Leukemia/Lymphoma/Myeloma; Pancreatic Cancer; Ovarian Cancer; Depression; Pain; Digestive System Inflammation; Digestive System Cancer; Urogenital Cancer NF-κB; PGC-1α Inhibitors & Agonists
HY-B0678R Metaxalone (Standard) Neurological, Eye or Ear Disease; Inflammation or Immune System Disease Reference Standards; NF-κB; PGC-1α Reference Standards
HY-B0678S Metaxalone-d3 Neurological, Eye or Ear Disease; Inflammation or Immune System Disease Isotope-Labeled Compounds; NF-κB; PGC-1α Isotope-Labeled Compounds
HY-B0678S1 Metaxalone-d6 Neurological, Eye or Ear Disease; Inflammation or Immune System Disease Isotope-Labeled Compounds; NF-κB; PGC-1α Isotope-Labeled Compounds
HY-B0718 Methoxyflurane Neurological, Eye or Ear Disease Potassium Channel Inhibitors & Agonists
HY-B0762 Acetyl-L-carnitine hydrochloride Parkinson's Disease; Breast Cancer; Prostate Cancer; Viral Infection; Digestive System Inflammation; Urogenital Cancer; Digestive System Disease Caspase; Apoptosis Inhibitors & Agonists
HY-B0762R Acetyl-L-carnitine hydrochloride (Standard) Neurological, Eye or Ear Disease Reference Standards; Endogenous Metabolite; Caspase; Apoptosis Reference Standards
HY-B0762S Acetyl-L-carnitine-d3 hydrochloride Neurological, Eye or Ear Disease Caspase; Apoptosis; Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-B0762S1 Acetyl-L-carnitine-d3-1 hydrochloride Neurological, Eye or Ear Disease Caspase; Apoptosis; Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-B0815 Chlorpyrifos Neurological, Eye or Ear Disease Environmental Pollutants; Cholinesterase (ChE) Inhibitors & Agonists
HY-B0815R Chlorpyrifos (Standard) Neurological, Eye or Ear Disease Reference Standards; Cholinesterase (ChE) Reference Standards
HY-B0979 Lobeline hydrochloride Alzheimer's Disease nAChR; Dopamine Transporter Inhibitors & Agonists
HY-B0979R Lobeline hydrochloride (Standard) Neurological, Eye or Ear Disease Reference Standards; nAChR; Dopamine Transporter Reference Standards
HY-B1110 Nomifensine Alzheimer's Disease; Hypertension; Depression Dopamine Receptor; Adrenergic Receptor Inhibitors & Agonists
HY-B1110A Nomifensine maleate Alzheimer's Disease; Hypertension; Depression Dopamine Receptor; Adrenergic Receptor Inhibitors & Agonists
HY-B1110AR Nomifensine maleate (Standard) Neurological, Eye or Ear Disease Dopamine Receptor; Adrenergic Receptor; Reference Standards Reference Standards
HY-B1110R Nomifensine (Standard) Neurological, Eye or Ear Disease Dopamine Receptor; Adrenergic Receptor; Reference Standards Reference Standards
HY-B1110S Nomifensine-d3 maleate Neurological, Eye or Ear Disease Isotope-Labeled Compounds; Dopamine Receptor; Adrenergic Receptor Isotope-Labeled Compounds
HY-B1287 Citalopram hydrobromide Breast Cancer; Viral Infection; Depression Serotonin Transporter; Autophagy Inhibitors & Agonists
HY-B1287R Citalopram hydrobromide (Standard) Breast Cancer; Neurological, Eye or Ear Disease Reference Standards; Serotonin Transporter; Autophagy Reference Standards
HY-B1287S Citalopram-d3 hydrobromide Cancer; Neurological, Eye or Ear Disease Autophagy; Serotonin Transporter; Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-B1315 Carbaryl Digestive System Inflammation; Neurological, Eye or Ear Disease; Digestive System Disease Reactive Oxygen Species (ROS); Environmental Pollutants; Cholinesterase (ChE); Apoptosis; Insecticide Inhibitors & Agonists
HY-B1315R Carbaryl (Standard) Neurological, Eye or Ear Disease; Inflammation or Immune System Disease Reference Standards; Insecticide; Cholinesterase (ChE); Reactive Oxygen Species (ROS); Apoptosis Reference Standards
HY-B1315S Carbaryl-d3 Neurological, Eye or Ear Disease; Inflammation or Immune System Disease Isotope-Labeled Compounds; Insecticide; Cholinesterase (ChE); Reactive Oxygen Species (ROS); Apoptosis Isotope-Labeled Compounds
HY-B1315S1 Carbaryl-d7 Neurological, Eye or Ear Disease; Inflammation or Immune System Disease Isotope-Labeled Compounds; Insecticide; Cholinesterase (ChE); Reactive Oxygen Species (ROS); Apoptosis Isotope-Labeled Compounds
HY-B1423 Lobeline Neurological, Eye or Ear Disease nAChR; Dopamine Transporter Inhibitors & Agonists
HY-B1789 Telenzepine Neurological, Eye or Ear Disease mAChR Inhibitors & Agonists
HY-D1438 RH 414 / Fluorescent Dye Fluorescent Dyes
HY-D1443 BSB / Amyloid-β Inhibitors & Agonists
HY-D1515 FM1-84 Neurological, Eye or Ear Disease Fluorescent Dye Fluorescent Dyes
HY-D1516 NerveGreen C3 / Fluorescent Dye Fluorescent Dyes
HY-D3394 SGC5 Others Fluorescent Dye Fluorescent Dyes
HY-E70074 Monoamine oxidase, plasma Neurological, Eye or Ear Disease Monoamine Oxidase Inhibitors & Agonists
HY-E70094 T4 UvsX Recombinase Others DNA/RNA Synthesis Inhibitors & Agonists
HY-G0017 N-Desmethyl imatinib Parkinson's Disease; Cancer Drug Metabolite; P-glycoprotein; Apoptosis Inhibitors & Agonists
HY-G0017A N-Desmethyl imatinib mesylate Parkinson's Disease; Cancer Drug Metabolite; P-glycoprotein; Apoptosis Inhibitors & Agonists
HY-G0017R N-Desmethyl imatinib (Standard) Others Reference Standards; Drug Metabolite; P-glycoprotein; Apoptosis Reference Standards
HY-G0017S N-Desmethyl imatinib-d8 Parkinson's Disease; Cancer Isotope-Labeled Compounds; Drug Metabolite; P-glycoprotein; Apoptosis Isotope-Labeled Compounds
HY-G0017S1 N-Desmethyl imatinib-d4 Parkinson's Disease; Cancer Isotope-Labeled Compounds; Drug Metabolite; P-glycoprotein; Apoptosis Isotope-Labeled Compounds
HY-I1070 D-Isoleucine Bacterial Infection; Neurodegenerative Disease; Pain ASCT Inhibitors & Agonists
HY-N0127 Yohimbine Hydrochloride SARS-CoV-2 Infection; Alzheimer's Disease; Hypertension; Depression; Glucose Metabolism Adrenergic Receptor Induced Disease Models Products
HY-N0127R Yohimbine Hydrochloride (Standard) Metabolic or Endocrine Disease Reference Standards; Adenosine Receptor Reference Standards
HY-N0413 Hupehenine Parkinson's Disease; Parasitic Infection; Digestive System Inflammation; Cancer; Digestive System Disease α-synuclein; Reactive Oxygen Species (ROS); Apoptosis; Autophagy; Parasite Inhibitors & Agonists
HY-N0413R Hupehenine (Standard) Cancer; Infection; Neurological, Eye or Ear Disease; Inflammation or Immune System Disease Reference Standards; α-synuclein; Reactive Oxygen Species (ROS); Apoptosis; Autophagy; Parasite Reference Standards
HY-N0698 Crocin II Parkinson's Disease; Cancer Endogenous Metabolite; α-synuclein Inhibitors & Agonists
HY-N0698R Crocin II (Standard) Cancer; Neurological, Eye or Ear Disease Reference Standards; Endogenous Metabolite; α-synuclein Reference Standards
HY-N0743 Senkyunolide A Parkinson's Disease; Depression; Cancer; Inflammation or Immune System Disease α-synuclein Inhibitors & Agonists
HY-N0901 Corynoxine Cancer; Neurological, Eye or Ear Disease Autophagy Inhibitors & Agonists
HY-N0901A Corynoxine B Parkinson's Disease; Cancer α-synuclein Inhibitors & Agonists
HY-N0901AR Corynoxine B (Standard) Cancer; Neurological, Eye or Ear Disease Reference Standards; α-synuclein Reference Standards
HY-N0901B Corynoxine hydrochloride Cancer; Neurological, Eye or Ear Disease Autophagy Inhibitors & Agonists
HY-N10772 Albanin A Neurological, Eye or Ear Disease; Inflammation or Immune System Disease Calcium Channel; Calmodulin; Adenylate Cyclase Inhibitors & Agonists
HY-N10889 Sominone Neurological, Eye or Ear Disease Drug Metabolite; RET Inhibitors & Agonists
HY-N15001 Gabaculine Neurological, Eye or Ear Disease GABA Receptor Inhibitors & Agonists
HY-N15613 α-Synuclein inhibitor 14 Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-N16524 Alpinin A Parkinson's Disease α-synuclein Inhibitors & Agonists
HY-N17816 Tambulin Lung Squamous Cell Carcinoma; Parkinson's Disease; Type 1 Diabetes; Cardiovascular Disease; Glucose Metabolism; Respiratory Cancer Apoptosis; Reactive Oxygen Species (ROS); α-synuclein; Succinate Dehydrogenase; Bcl-2 Family; Caspase Inhibitors & Agonists
HY-N18289 8-Hydroxydihydrochelerythrine Alzheimer's Disease Cholinesterase (ChE) Inhibitors & Agonists
HY-N2099 Onjisaponin B Alzheimer's Disease; Parkinson's Disease; Leukemia/Lymphoma/Myeloma; Obesity; Breast Cancer; Prostate Cancer; Liver Cancer; Leukemia/Lymphoma/Myeloma; Pancreatic Cancer; Ovarian Cancer; Depression; Pain; Digestive System Inflammation; Digestive System Cancer; Urogenital Cancer Autophagy; Amyloid-β; Caspase; NF-κB; Apoptosis Inhibitors & Agonists
HY-N2099A (Z)-Onjisaponin B Neurological, Eye or Ear Disease; Inflammation or Immune System Disease; Metabolic or Endocrine Disease Drug Derivative Inhibitors & Agonists
HY-N2326 (±)-Anatoxin A fumarate Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease nAChR Inhibitors & Agonists
HY-N3198A Sophoramine Arrhythmias Adrenergic Receptor Inhibitors & Agonists
HY-N6745 Citreoviridin Infection; Blood or Cardio-cerebrovascular Disease Na+/K+ ATPase; Apoptosis Inhibitors & Agonists
HY-N6776 Penitrem A Cancer; Neurological, Eye or Ear Disease Potassium Channel Induced Disease Models Products
HY-N6776R Penitrem A (Standard) Cancer; Neurological, Eye or Ear Disease Reference Standards; Potassium Channel Reference Standards
HY-N7981 Pratensein Alzheimer's Disease; Leukemia/Lymphoma/Myeloma; Obesity; Breast Cancer; Prostate Cancer; Liver Cancer; Leukemia/Lymphoma/Myeloma; Pancreatic Cancer; Ovarian Cancer; Depression; Pain; Digestive System Inflammation; Digestive System Cancer; Urogenital Cancer NF-κB Inhibitors & Agonists
HY-N8210 Homoeriodictyol Leukemia/Lymphoma/Myeloma; Obesity; Lung Fibrosis; Breast Cancer; Prostate Cancer; Leukemia/Lymphoma/Myeloma; Pancreatic Cancer; Ovarian Cancer; Depression; Pain; Digestive System Inflammation; Digestive System Cancer; Urogenital Cancer Drug Metabolite; Autophagy; Apoptosis; Reactive Oxygen Species (ROS); Keap1-Nrf2; MMP; Caspase; PARP; MDM-2/p53 Inhibitors & Agonists
HY-N8210R Homoeriodictyol (Standard) Cancer; Neurological, Eye or Ear Disease; Inflammation or Immune System Disease Reference Standards; Drug Metabolite; Autophagy; Apoptosis; Reactive Oxygen Species (ROS); Keap1-Nrf2; MMP; Caspase; PARP; MDM-2/p53 Reference Standards
HY-N8693 Withanoside IV SARS-CoV-2 Infection; Alzheimer's Disease COX; Amyloid-β; Sirtuin; Reactive Oxygen Species (ROS); Apoptosis; SARS-CoV Inhibitors & Agonists
HY-NP180 Progesterone/BSA Metabolic or Endocrine Disease Calcium Channel Inhibitors & Agonists
HY-P0062 Ziconotide Cancer; Neurological, Eye or Ear Disease; Inflammation or Immune System Disease Calcium Channel Peptides
HY-P0062A Ziconotide TFA Experimental Autoimmune Encephalomyelitis; Experimental Autoimmune Encephalomyelitis; Cancer Calcium Channel Peptides
HY-P0062B Ziconotide acetate Cancer; Inflammation or Immune System Disease; Blood or Cardio-cerebrovascular Disease Calcium Channel Peptides
HY-P0099 Pentapeptide-3 / nAChR Peptides
HY-P10282 Synapsin I-(3-13) Neurological, Eye or Ear Disease CaMK Peptides
HY-P10360 Tat-βsyn-degron Neurological, Eye or Ear Disease α-synuclein Peptides
HY-P10404 PDpep1.3 Neurological, Eye or Ear Disease α-synuclein Peptides
HY-P10430 Stalk peptide Neurological, Eye or Ear Disease Transmembrane Glycoprotein Peptides
HY-P1054 pep2-EVKI Neurological, Eye or Ear Disease PKC Peptides
HY-P1057 Pep4c Neurological, Eye or Ear Disease iGluR Peptides
HY-P1058 Pep2m Neurological, Eye or Ear Disease iGluR Peptides
HY-P10630 Pep63 Neurological, Eye or Ear Disease Amyloid-β Peptides
HY-P10844 ANK peptide / Amino Acid Derivatives Peptides
HY-P10979 Buccalin Neurological, Eye or Ear Disease Neuropeptide S Receptor Peptides
HY-P11263 AVLX-144 Parkinson's Disease iGluR Peptides
HY-P11319 RAP-103 Neurological, Eye or Ear Disease CCR Peptides
HY-P11581 MNP2 Neurodegenerative Disease NOD-like Receptor (NLR); Interleukin Related; Caspase; Amyloid-β; Tau Protein; α-synuclein; Pyroptosis Peptides
HY-P1297 CRF(6-33)(human) Neurological, Eye or Ear Disease CRFR Peptides
HY-P1297A CRF(6-33)(human) TFA Neurological, Eye or Ear Disease CRFR Peptides
HY-P1363 β-Amyloid (1-42), human TFA Alzheimer's Disease Amyloid-β Induced Disease Models Products
HY-P1363A β-Amyloid (1-42), human Alzheimer's Disease Amyloid-β Induced Disease Models Products
HY-P1363B β-Amyloid (1-42), human, HFIP-treated Alzheimer's Disease Amyloid-β Induced Disease Models Products
HY-P1363S1 β-Amyloid (1-42), human, Ala(13C3,15N) TFA Neurological, Eye or Ear Disease Isotope-Labeled Compounds; Amyloid-β Isotope-Labeled Compounds
HY-P1386 D15 Neurological, Eye or Ear Disease iGluR Peptides
HY-P1544 Cerebellin Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease Endogenous Metabolite; Adenylate Cyclase; PKA; Calcium Channel Peptides
HY-P1544A Cerebellin TFA Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease Adenylate Cyclase; Calcium Channel; PKA; Endogenous Metabolite Peptides
HY-P1716 Neuropeptide DF2 Neurological, Eye or Ear Disease PKC Peptides
HY-P2210A BigLEN(mouse) TFA Neurological, Eye or Ear Disease GPR171 Peptides
HY-P2259 TAT-GluA2 3Y Neurological, Eye or Ear Disease; Blood or Cardio-cerebrovascular Disease iGluR; HIV Integrase; Adenosine Receptor Peptides
HY-P2264 KYL peptide Inflammation or Immune System Disease Ephrin Receptor Peptides
HY-P2471 Neurogranin (48-76), mouse Neurological, Eye or Ear Disease Calmodulin Peptides
HY-P2860 Acetylcholinesterase, Fly head Neurological, Eye or Ear Disease Cholinesterase (ChE) Inhibitors & Agonists
HY-P2860A Acetylcholinesterase, Electric eel Neurological, Eye or Ear Disease Cholinesterase (ChE) Inhibitors & Agonists
HY-P3071 ShK toxin Neurological, Eye or Ear Disease; Inflammation or Immune System Disease Potassium Channel Peptides
HY-P3071A ShK toxin TFA Neurological, Eye or Ear Disease; Inflammation or Immune System Disease Potassium Channel Peptides
HY-P3089 Dendrotoxin K Others Potassium Channel Peptides
HY-P3089A Dendrotoxin K TFA / Potassium Channel Peptides
HY-P3095 α-Latrotoxin Neurological, Eye or Ear Disease Endogenous Metabolite Peptides
HY-P3140 α-Synuclein (61-75) Neurological, Eye or Ear Disease α-synuclein Peptides
HY-P3140A α-Synuclein (61-75) TFA Neurological, Eye or Ear Disease α-synuclein Peptides
HY-P3247 [D-Ala2]-GIP (human) Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease Insulin Receptor Peptides
HY-P3340 Leptin (116-130) Neurological, Eye or Ear Disease iGluR Peptides
HY-P3443 Peanut agglutinin Leukemia/Lymphoma/Myeloma; Leukemia/Lymphoma/Myeloma Biochemical Assay Reagents Inhibitors & Agonists
HY-P4397 (d(CH2)51,Tyr(Me)2,Thr4,Orn8,des-Gly-NH29)-Vasotocin Metabolic or Endocrine Disease Oxytocin Receptor Peptides
HY-P4610 H-Trp-Tyr-OH Glucose Metabolism GLP Receptor Peptides
HY-P4704 α-Synuclein (61-95) (human) Neurological, Eye or Ear Disease α-synuclein Peptides
HY-P4704A α-Synuclein (61-95) (human) TFA Neurological, Eye or Ear Disease α-synuclein Peptides
HY-P5041 α-Synuclein (34-45) (human) Neurological, Eye or Ear Disease α-synuclein Peptides
HY-P5044 α-Synuclein (45-54) (human) Neurological, Eye or Ear Disease α-synuclein Peptides
HY-P5046 α-Synuclein (71-82) (human) Neurological, Eye or Ear Disease α-synuclein Peptides
HY-P5082 α-Synuclein 4554W Parkinson's Disease α-synuclein Peptides
HY-P5859 α-Pompilidotoxin Neurological, Eye or Ear Disease Biochemical Assay Reagents Peptides
HY-P990905 Bexatamig Acute Myeloid Leukemia Interleukin Related Inhibitors & Agonists
HY-P990925 Linclatamig Inflammation or Immune System Disease CD3 Inhibitors & Agonists
HY-P991155 Ramantamig Multiple Myeloma CD3; TNF Receptor Inhibitors & Agonists
HY-P991535 PMN310 Neurological, Eye or Ear Disease Amyloid-β Inhibitors & Agonists
HY-P991654 SAR228810 Neurological, Eye or Ear Disease Amyloid-β Inhibitors & Agonists
HY-P992457 SAR444200 Lung Squamous Cell Carcinoma; Liver Cancer; Skin Cancer; Respiratory Cancer; Digestive System Cancer Glycoprotein VI; Interleukin Related Inhibitors & Agonists
HY-P992512 ANX-M1 (Mouse IgG1) Alzheimer's Disease; Huntington's Disease; Retinopathy; Pain Complement System Inhibitors & Agonists
HY-P99356 Cinpanemab Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-P99405 Prasinezumab Neurological, Eye or Ear Disease α-synuclein Inhibitors & Agonists
HY-P99601 Cevostamab Cancer; Neurological, Eye or Ear Disease CD3 Inhibitors & Agonists
HY-P99618 Fidasimtamab Gastric Cancer; Digestive System Cancer EGFR; PD-1/PD-L1 Inhibitors & Agonists
HY-W002199 6:2 Fluorotelomer alcohol Bacterial Infection; Neurological, Eye or Ear Disease Bacterial; Apoptosis; ERK; TNF Receptor Inhibitors & Agonists
HY-W008610 GBR 12783 Neurological, Eye or Ear Disease Dopamine Receptor Inhibitors & Agonists
HY-W012735 (+)-Nipecotic acid Alzheimer's Disease; Parkinson's Disease; Depression GABA Receptor Inhibitors & Agonists
HY-W015912S 2-Acetylfuran-d3 / Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-W040555 Norquetiapine dihydrochloride Depression Drug Metabolite; 5-HT Receptor; HCN Channel; Serotonin Transporter Inhibitors & Agonists
HY-W041892 Dimethyl itaconate Infection; Neurological, Eye or Ear Disease; Inflammation or Immune System Disease Reactive Oxygen Species (ROS) Inhibitors & Agonists
HY-W042156 Aegeline Parkinson's Disease; Fungal Infection Fungal Inhibitors & Agonists
HY-W042156R Aegeline (Standard) Neurological, Eye or Ear Disease Reference Standards; Fungal Reference Standards
HY-W049881 9-Methyl-β-carboline Parkinson's Disease Dopamine Receptor; PI3K; Monoamine Oxidase Inhibitors & Agonists
HY-W052508 Norquetiapine Alzheimer's Disease; Depression Drug Metabolite; 5-HT Receptor; HCN Channel; Serotonin Transporter Inhibitors & Agonists
HY-W052508S Norquetiapine-d8 Neurological, Eye or Ear Disease; Inflammation or Immune System Disease Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-W067716 Spinacine Neurological, Eye or Ear Disease GABA Receptor Inhibitors & Agonists
HY-W067716R Spinacine (Standard) Neurological, Eye or Ear Disease Reference Standards; GABA Receptor Reference Standards
HY-W127407 Glycerophospho-N-arachidonoyl ethanolamine / Biochemical Assay Reagents Inhibitors & Agonists
HY-W247131 DASPEI Neurological, Eye or Ear Disease Fluorescent Dye Fluorescent Dyes
HY-W278867 trans-3,5-Dimethoxystilbene Lung Fibrosis; Neurodegenerative Disease Cholinesterase (ChE) Inhibitors & Agonists
HY-W278867R trans-3,5-Dimethoxystilbene (Standard) Neurodegenerative Disease Reference Standards; Cholinesterase (ChE) Reference Standards
HY-W380450 Viloxazine Alzheimer's Disease 5-HT Receptor Inhibitors & Agonists
HY-W436420 WAY-299375 / Drug Derivative Inhibitors & Agonists
HY-W657887 GSK-3β/G9a-IN-1 Alzheimer's Disease Histone Methyltransferase; GSK-3; Tau Protein; Amyloid-β; Glucocorticoid Receptor; Androgen Receptor; Adrenergic Receptor Inhibitors & Agonists
HY-W674257 WAY-658674 / Drug Derivative Inhibitors & Agonists
HY-W674612 WAY-297848 / Drug Derivative Inhibitors & Agonists
HY-W674624 WAY-312858 / Drug Derivative Inhibitors & Agonists
HY-W707498 Baclofen-d4-1 Neurological, Eye or Ear Disease GABA Receptor; Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-W707528 Propofol-d14 Neurological, Eye or Ear Disease GABA Receptor; Endogenous Metabolite; Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-W708023 5-APDI hydrochloride Neurological, Eye or Ear Disease 5-HT Receptor Inhibitors & Agonists
HY-W720917 Junicedric acid Alzheimer's Disease PKC; Amyloid-β; CaMK; Apoptosis Inhibitors & Agonists
HY-W747910A S584 dihydrochloride Oxidative Stress and Inflammation Drug Metabolite Inhibitors & Agonists
HY-W753806 Doxazosin hydrochloride Blood or Cardio-cerebrovascular Disease Akt Inhibitors & Agonists
HY-W765177 Acetyl-L-carnitine hydrochloride-13C3 Neurological, Eye or Ear Disease Caspase; Apoptosis; Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-W793473 WAY-301398 / Drug Derivative Inhibitors & Agonists
HY-W795507 Cyanopindolol Alzheimer's Disease; Parkinson's Disease; Hypertension; Obesity; Depression Adrenergic Receptor; 5-HT Receptor Inhibitors & Agonists
HY-W795736 (+)-Vesamicol Neurological, Eye or Ear Disease nAChR Inhibitors & Agonists
HY-Y0282 Sodium bromide Epilepsy Environmental Pollutants Inhibitors & Agonists
HY-Y0364 Ethyl 2-chloroacetoacetate Fungal Infection Fungal Inhibitors & Agonists
HY-Y0378 D-Leucine Neurological, Eye or Ear Disease Endogenous Metabolite Inhibitors & Agonists
HY-Y0378R D-Leucine (Standard) Neurological, Eye or Ear Disease Reference Standards; Endogenous Metabolite Reference Standards
HY-Y0378S D-Leucine-d10 Neurological, Eye or Ear Disease Isotope-Labeled Compounds; Endogenous Metabolite Isotope-Labeled Compounds
HY-Y0790S Cuminaldehyde-d8 Cancer Endogenous Metabolite; Isotope-Labeled Compounds Isotope-Labeled Compounds
HY-Y0808 Dimethyl succinate Digestive System Inflammation; Neurological, Eye or Ear Disease; Metabolic or Endocrine Disease; Digestive System Disease Environmental Pollutants; Apoptosis Inhibitors & Agonists

Reference

[1]. Bliss TVP, et al. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993;361(6407):31-39.  [Content Brief]

[2]. Malenka RC, et al. LTP and LTD: an embarrassment of riches. Neuron. 2004;44(1):5-21.  [Content Brief]

[3]. Citri A, et al. Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology. 2008;33(1):18-41.  [Content Brief]

[4]. Turrigiano GG. The self-tuning neuron: synaptic scaling of excitatory synapses. Cell. 2008;135(3):422-435.et al. The self-tuning neuron: synaptic scaling of excitatory synapses. Cell. 2008;135(3):422-435.  [Content Brief]

[5]. Holtmaat A, et al. Experience-dependent structural synaptic plasticity in the mammalian brain. Nat Rev Neurosci. 2009;10(9):647-658.  [Content Brief]

[6]. Park H, et al. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci. 2013;14(1):7-23.  [Content Brief]

[7]. Huganir RL, et al. AMPARs and synaptic plasticity: the last 25 years. Neuron. 2013;80(3):704-717.  [Content Brief]

[8]. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science. 2002;298(5594):789-791.et al. Alzheimer's disease is a synaptic failure. Science. 2002;298(5594):789-791.  [Content Brief]

[9]. Spires-Jones TL, et al. The intersection of amyloid beta and tau at synapses in Alzheimer's disease. Neuron. 2014;82(4):756-771.  [Content Brief]

[10]. Cramer SC, et al. Harnessing neuroplasticity for clinical applications. Brain. 2011;134(Pt 6):1591-1609.  [Content Brief]

[11]. Mayford M, et al. Synapses and memory storage. Cold Spring Harb Perspect Biol. 2012;4(6).  [Content Brief]

Keywords：synaptic plasticity | brain health | neuroplasticity | long-term potentiation | long-term depression | learning and memory | AMPA receptor trafficking | NMDA receptor signaling | CaMKII | BDNF | dendritic spine remodeling | Alzheimer’s disease | cognitive decline | neurorehabilitation | neural circuit remodeling